Status:
RECRUITING
Analysis of the Prevalence of Sensitization to Plants Containing Gibberellins Using Realistic Skin Prick Tests
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Food Allergy
Eligibility:
All Genders
5+ years
Phase:
NA
Brief Summary
Gibberellin-related proteins (GRPs) are proteins contained in both pollens and vegetables and are associated with an increased risk of severe food allergy reactions. The best characterized one the onl...
Eligibility Criteria
Inclusion
- Patients aged at least 5 years
- Patients consulting at the Allergy Unit of the University Hospital of Montpellier for any type of allergy work-up/evaluation
- Oral consent from the patient and, where applicable, from at least one of the patient's legal representatives in the case of minors.
Exclusion
- Patients treated with antihistamines or psychotropic drugs with antihistaminic action during the 7 days prior to inclusion
- Patients with pathologies that prevent the performance of prick tests (e.g. severe peripheral neuropathy, cutaneous anergy).
- Patients with dermographism.
- Patient taking part in another study which may influence the results of the prick tests.
- Patients in an exclusion period determined by a previous study.
- Pregnant, parturient or breast-feeding women.
- Patients or their legal representatives under court protection, guardianship or trusteeship.
- Patients or their legal representatives who are not members or beneficiaries of a health insurance scheme.
- Patient or his/her legal representative unable to read and understand French fluently.
Key Trial Info
Start Date :
March 14 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 14 2028
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT06183398
Start Date
March 14 2024
End Date
March 14 2028
Last Update
October 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital of Montpellier
Montpellier, France, 34295